NCT01743313 Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement Status TERMINATED Phase N/A
NCT01730053 Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II) Status COMPLETED Phase PHASE3
NCT01730040 Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I) Status COMPLETED Phase PHASE3
NCT01723735 Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01720537 A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects Status COMPLETED Phase PHASE1
NCT01717300 A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021) Status COMPLETED Phase PHASE3
NCT01710007 Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT01709513 Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE) Status COMPLETED Phase PHASE3
NCT01705873 Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen Status UNKNOWN Phase N/A
NCT01702987 Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS Status COMPLETED Phase NA
NCT01678521 Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients Status COMPLETED Phase N/A
NCT01671085 A Study of LY3015014 in Healthy Participants With High Cholesterol Status COMPLETED Phase PHASE1
NCT01670734 Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects Status COMPLETED Phase PHASE1